Annual EBITDA
$29.32B$4.18B+16.63%
Summary
- Current Value
- As of today, MRK annual EBITDA is $29.32B, up +16.63% on
- Historical Performance
- MRK annual EBITDA is up +25.26% over the past 3 years, up +116.48% over the past 5 years
- All-Time High Comparison
- MRK annual EBITDA is currently at its all-time high
- 3-Year Low Comparison
- MRK annual EBITDA is +327.84% above its 3-year low of $6.85B reached on
- Sector Comparison
- MRK annual EBITDA is higher than 99.83% of companies in Healthcare sector
EBITDA Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $29.32B | +16.6% | +25.3% | +116.5% | +107.2% | |
| Quarterly EBITDA | -$458.00M | -105.9% | -109.3% | -112.5% | -110.0% | |
| TTM EBITDA | $24.12B | -9.6% | +12.4% | +83.7% | +49.7% | |
| Price | $113.45 | +54.4% | -3.1% | +51.9% | +220.7% | |
| PE Ratio | 31.93 | +198.4% | +39.5% | +18.2% | -53.1% | |
| Annual Revenue | $64.93B | +1.5% | +11.0% | +56.3% | +41.4% | |
| Annual EPS | $7.28 | +8.1% | +27.5% | +161.8% | +2500.4% | |
| Annual EBIT | $26.78B | +29.7% | +37.3% | +166.2% | +295.4% | |
| Annual Net Income | $18.26B | +6.6% | +25.7% | +303.8% | +1763.6% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $29.32B | at high | |
| 5Y | $29.32B | at high | |
| All | $29.32B | at high |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $6.85B | +327.8% | |
| 5Y | $6.85B | +327.8% | |
| All | $695.88M | +4114.0% |
EBITDA History
FAQ
What is the current annual EBITDA of MRK?
As of today, MRK annual EBITDA is $29.32B
What is 1-year change in MRK annual EBITDA?
MRK annual EBITDA is up +16.63% year-over-year
What is 3-year change in MRK annual EBITDA?
MRK annual EBITDA is up +25.26% over the past 3 years
How far is MRK annual EBITDA from its all-time high?
MRK annual EBITDA is currently at its all-time high
How does MRK annual EBITDA rank versus sector peers?
MRK annual EBITDA is higher than 99.83% of companies in Healthcare sector
When is MRK next annual earnings release?
As of today, the next annual earnings release for MRK has not been scheduled
Quarterly EBITDA
-$458.00M$9.08B-105.31%
Summary
- Current Value
- As of today, MRK quarterly EBITDA is -$458.00M, down -105.31% on
- Historical Performance
- MRK quarterly EBITDA is down -105.87% year-over-year, down -109.30% over the past 3 years
- All-Time High Comparison
- MRK quarterly EBITDA is currently -105.31% below its historical high of $8.63B set on
- 3-Year Low Comparison
- MRK quarterly EBITDA is +88.54% above its 3-year low of -$4.00B reached on
- Sector Comparison
- MRK quarterly EBITDA is higher than 0.28% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | -$458.00M | -105.3% | -105.9% | -109.3% | -112.5% | |
| Annual EBITDA | $29.32B | – | +16.6% | +25.3% | +116.5% | |
| TTM EBITDA | $24.12B | -25.5% | -9.6% | +12.4% | +83.7% | |
| Price | $113.45 | -6.6% | +54.4% | -3.1% | +51.9% | |
| PE Ratio | 31.93 | +91.3% | +198.4% | +39.5% | +18.2% | |
| Quarterly Revenue | $16.20B | -0.8% | +3.7% | +11.1% | +54.0% | |
| Quarterly EPS | -$1.72 | -244.0% | -185.5% | -255.1% | -237.1% | |
| Quarterly EBIT | -$1.88B | -130.6% | -128.1% | -147.9% | -168.3% | |
| Quarterly Net Income | -$4.24B | -243.3% | -183.4% | -250.2% | -254.3% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $8.63B | -105.3% | |
| 3Y | $8.63B | -105.3% | |
| 5Y | $8.63B | -105.3% | |
| All | $8.63B | -105.3% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$458.00M | at low | |
| 3Y | -$4.00B | +88.5% | |
| 5Y | -$4.00B | +88.5% | |
| All | -$4.00B | +88.5% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of MRK?
As of today, MRK quarterly EBITDA is -$458.00M
What is MRK quarterly EBITDA most recent change?
MRK quarterly EBITDA was down -105.31% on March 31, 2026
What is 1-year change in MRK quarterly EBITDA?
MRK quarterly EBITDA is down -105.87% year-over-year
How far is MRK quarterly EBITDA from its all-time high?
MRK quarterly EBITDA is currently -105.31% below its historical high of $8.63B set on December 31, 2025
How does MRK quarterly EBITDA rank versus sector peers?
MRK quarterly EBITDA is higher than 0.28% of companies in Healthcare sector
When is MRK next earnings release?
The next earnings release for MRK is on
TTM EBITDA
$24.12B$8.27B-25.53%
Summary
- Current Value
- As of today, MRK TTM EBITDA is $24.12B, down -25.53% on
- Historical Performance
- MRK TTM EBITDA is down -9.62% year-over-year, up +12.43% over the past 3 years
- All-Time High Comparison
- MRK TTM EBITDA is currently -25.53% below its historical high of $32.39B set on
- 3-Year Low Comparison
- MRK TTM EBITDA is +248.78% above its 3-year low of $6.92B reached on
- Sector Comparison
- MRK TTM EBITDA is higher than 99.63% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $24.12B | -25.5% | -9.6% | +12.4% | +83.7% | |
| Annual EBITDA | $29.32B | – | +16.6% | +25.3% | +116.5% | |
| Quarterly EBITDA | -$458.00M | -105.3% | -105.9% | -109.3% | -112.5% | |
| Price | $113.45 | -6.6% | +54.4% | -3.1% | +51.9% | |
| PE Ratio | 31.93 | +91.3% | +198.4% | +39.5% | +18.2% | |
| TTM Revenue | $65.51B | +0.9% | +2.7% | +14.7% | +57.3% | |
| TTM EPS | $3.55 | -51.2% | -48.3% | -30.6% | +28.5% | |
| TTM EBIT | $18.10B | -32.2% | -18.3% | +2.4% | +90.5% | |
| TTM Net Income | $8.93B | -51.1% | -48.8% | -31.5% | +85.9% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $32.39B | -25.5% | |
| 3Y | $32.39B | -25.5% | |
| 5Y | $32.39B | -25.5% | |
| All | $32.39B | -25.5% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $24.12B | at low | |
| 3Y | $6.92B | +248.8% | |
| 5Y | $6.92B | +248.8% | |
| All | $788.50M | +2958.7% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of MRK?
As of today, MRK TTM EBITDA is $24.12B
What is MRK TTM EBITDA most recent change?
MRK TTM EBITDA was down -25.53% on March 31, 2026
What is 1-year change in MRK TTM EBITDA?
MRK TTM EBITDA is down -9.62% year-over-year
How far is MRK TTM EBITDA from its all-time high?
MRK TTM EBITDA is currently -25.53% below its historical high of $32.39B set on December 31, 2025
How does MRK TTM EBITDA rank versus sector peers?
MRK TTM EBITDA is higher than 99.63% of companies in Healthcare sector
When is MRK next earnings release?
The next earnings release for MRK is on
EBITDA Formula
Data Sources & References
- MRK Official Website www.merck.com
- MRK Profile on Yahoo Finance finance.yahoo.com/quote/MRK
- MRK Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/mrk